// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The burden of adult growth hormone deficiency diagnostic tests: results of a patient experience survey in the UK

Harry Lewis - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

hGH

Ruptured rathke’s cleft cyst (RCC) with irritation of optic apparatus and rapidly evolving panhypopituitarism

Annalisa Montebello - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Neurohypophyseal diabetes insipidus

Hydrocortisone

European Registries for Rare Endocrine Conditions (EuRRECa): results from the e-Reporting platform for rare conditions (e-REC)

Salma Rashid Ali - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Intranasal kisspeptin administration stimulates reproductive hormone secretion in healthy volunteers and patients with hypogonadism

Edouard Mills - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Glycaemic and metabolic effects of testosterone replacement in hypogonadal men with uncontrolled type 2 diabetes − a randomised double blinded placebo controlled trial − stride study

Preethi Mohan Rao - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

LPCN 1111

The effect of testosterone on quality of life, constitutional symptoms, sexual function and memory − randomised placebo-controlled study in hypogonadal men with uncontrolled type 2 diabetes − stride study

Preethi Mohan Rao - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

LPCN 1111

FSH and bone: comparison between males with central vs primary hypogonadism

Luca Giovanelli - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Simulation via instant messaging − birmingham advance (SIMBA) as a tool to bridge gaps in clinical knowledge and expectations between physicians and patients with polycystic ovary syndrome

Pavithra Sakthivel - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

N/A

Blue Morpho: An international survey investigating differences in emotional and psychosexual wellbeing by ethnicity and birthplace in women with polycystic ovary syndrome

Jameela Sheikh - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Polycystic Ovary Syndrome

N/A

Kisspeptin improves sexual brain processing in women with low sexual desire

Layla Thurston - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Global impact of PCOS awareness month: challenges and opportunities

Kashish Malhotra - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

N/A

A systematic review and meta-analysis assessing psychosexual wellbeing in people with polycystic ovary syndrome

Halimah Khalil - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

N/A

Andrological effects of SARS-Cov2 infection: a systematic review and meta-analysis

Walter Vena - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical/biochemical characteristics of functioning gonadotroph adenomas in women presenting with ovarian hyperstimulation

Nikoleta Papanikolaou - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Ovarian hyperstimulation syndrome

N/A

The biochemical investigation of PCOS: a UK wide survey of laboratory practice

James M Hawley - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

N/A

Cyproterone associated meningioma in a polycystic ovarian syndrome patient- a rare occurrence in our cohort

Ali Al Jumaah - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Polycystic Ovary Syndrome

Neogynon

Early career clinicians’ knowledge about lifestyle management of PCOS and the current practices of implementing it in clinical practice - does more need to be done?

Nawal Zia - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

N/A

Identifying the use of clinical and radiological parameters to assess moderate-severe Graves’ Orbitopathy − a multi-centre analysis of the characteristics of patients with Graves’ Orbitopathy

Nicole George - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Severe refractory active thyroid eye disease: an unmet clinical need in Europe

Ploutarchos Tzoulis - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Congenital hyperthyroidism

Methylprednisolone

A case of severe hypothyroidism causing reversible chronic kidney disease

Veshalee Vernugopan - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic kidney disease

Levothyroxine

Copyright © 2026. QuantiNova All rights reserved